Driving Change with SEIS & EIS: A Quick Overview
Early-stage life science ventures need more than funding—they need fair access, diverse perspectives and actionable guidance. That’s where SEIS and EIS step in. These UK government schemes offer up to 50% tax relief for Seed Enterprise Investment Scheme (SEIS) and 30–45% for Enterprise Investment Scheme (EIS), making it easier for investors to back innovative biotech, medtech and digital health startups.
Gender equity in this sector isn’t just right, it pays off. Firms with diverse boards report 27% higher likelihood of outperformance. Women-led teams bring fresh insights and foster inclusive growth. Yet only 19% of investment roles in life science are held by women. We need to close that gap. You can start by exploring Revolutionising investment mentorship UK opportunities through Oriel IPO’s curated investment marketplace, designed to connect diverse founders with angel investors—and harness the power of SEIS & EIS for maximum impact.
The Imperative for Gender Equity in Life Sciences
Gender equity isn’t a checkbox. It’s foundational. When you widen the talent pool, you spark innovation. Consider these facts:
- Women make up just 38% of the UK life science investment workforce.
- Only 22% occupy leadership roles.
- A mere 19% hold direct investment responsibilities.
These numbers aren’t destiny. They’re a call to action. Investors know that teams in the top quartile for gender diversity outperform the bottom quartile by 45 basis points per annum (net excess returns). Boards with mixed representation report stronger inclusive growth. The verdict? Diversity drives performance.
Breaking barriers requires collective effort:
- Allyship and mentorship
- Specialist resources and training
- Access to networks of peers and investors
Groups like Invest in Equity have done great work in guidance and advocacy. But they stop short of directly streamlining funding through tax-efficient channels like SEIS and EIS. That’s where Oriel IPO steps up.
SEIS & EIS: Powerful Tools for Diversifying Investment
Tax relief can tilt the scales. Here’s how:
-
Seed Enterprise Investment Scheme (SEIS)
– Up to £150,000 per investor per company.
– 50% income tax relief on investments.
– 50% CGT reinvestment relief on disposal gains. -
Enterprise Investment Scheme (EIS)
– Up to £1 million per investor (or £2 million for knowledge-intensive).
– 30% income tax relief.
– 100% CGT deferral on gains.
More tax relief. Less risk. That attracts a broader investor base. And a bigger pool means more chances for women founders to get backing.
Why It Matters for Female Founders
- Lower upfront cost: Tax incentives reduce net outlay.
- Better valuations: Early funding on favourable terms.
- Investor appeal: Angels and VCs chase SEIS/EIS deals.
But navigating compliance, paperwork and investor matching isn’t trivial. Traditional channels can be opaque. You need clarity and support at every step.
Invest in Equity vs Oriel IPO: A Comparative Lens
When it comes to advancing gender equity in life science investment, two models emerge.
Invest in Equity: Strengths and Scope
Invest in Equity excels at:
- Mentorship & sponsorship: Connecting women with experienced backers.
- Resources & training: Webinars, guides and tailored workshops.
- Networking events: Invitation-only roundtables with industry leaders.
They build community, offer allyship and share data on gender diversity. All critical elements. Yet, they don’t operate a direct investment marketplace. There is no built-in SEIS/EIS integration. Founders still juggle multiple platforms for funding and tax relief.
Oriel IPO: Bridging the Gap
Oriel IPO takes those advocacy wins further:
- Commission-free curated marketplace: Keep 100% of funds raised—no hidden fees.
- SEIS/EIS expertise: Vetted startups meet eligibility, simplified compliance.
- Educational hub: Webinars, guides and real-time tax calculators.
- Direct investor access: Angels and advisers in one central space.
In short, Oriel IPO merges mentoring ambitions with hands-on funding solutions. It doesn’t just talk equity—it enables it. Access expert investment mentorship UK guidance on our platform and see the difference.
Practical Steps for Female Founders to Leverage SEIS & EIS
Ready to take action? Here’s a simple roadmap:
-
Assess eligibility
Review your business scope, trading history and size. Oriel IPO’s SEIS/EIS checker flags any red tape early. -
Gather paperwork
Articles of association, shareholder registers and R&D project details. Pre-prepare to speed up approvals. -
Engage professional advisers
Accountants or tax advisers can fine-tune your submission. We partner with leading networks to simplify this. -
List on Oriel IPO
Create a profile, upload documents and highlight your team’s diversity credentials. Our vetting team steps in next. -
Connect with investors
Angels browsing SEIS/EIS opportunities find you. They see your gender equity focus front and centre. -
Secure funding
Benefit from up to 50% SEIS tax relief on investments. More attractive terms. Faster rounds.
By combining community advocacy with tax-efficient funding, you expand your runway and your network. And you help shift the sector’s balance, one investment at a time.
Building a More Equitable Ecosystem Together
A thriving life science scene needs diverse voices. Here’s how every stakeholder plays a part:
-
Accountants & tax advisers
Help clients claim SEIS/EIS relief. Use Oriel IPO’s tools for clear workflows. -
Investors
Broaden your portfolio with gender-diverse teams. Enjoy robust returns and inclusive growth. -
Founders
Prepare your pitch, showcase impact and scale with confidence.
Oriel IPO’s commission-free model encourages everyone to play fair. Founders keep more capital. Investors access top-quality, vetted deals. Expertise is shared—through videos, articles and live Q&A sessions.
Conclusion: Empowering Diverse Founders with Tax-Efficient Investment
Advancing gender equity in UK life science isn’t a solo journey. It’s a shared mission. SEIS and EIS create powerful incentives. Mentorship groups like Invest in Equity pave the way. But to truly shift funding patterns, you need an integrated platform that combines advocacy with action.
Oriel IPO delivers that bridge. Our curated marketplace, expert resources and seamless SEIS/EIS support mean you can focus on what matters—innovation, impact and inclusive growth.
Ready to make a real difference? Get personalised investment mentorship UK insights and join the next generation of life science leaders.
